NFKB1 and neoplasm: Over the past decades, extensive studies have delineated its canonical and non-canonical pathways (3, 4), yet the nuanced modulation of NF-κB activity via post-translational modifications (PTMs) remains an evolving frontier with profound implications for tumor immunology (5, 6).